KMT2A and myeloid neoplasm: KMT2A fusions were the most common (n = 28, 60%, GRIN p = 1.86 × 10−74)(Fig. 3a, Supplementary Data 18–20, & Supplementary Fig. 9) and other in-frame fusions previously reported in myeloid malignancies involving NUP98 (n = 3) and ETV6 (n = 2) were also observed32–34.